Fortis Healthcare on Thursday said its board has accorded in-principal approval to acquire 86 per cent stake in Super Religare Laboratoriesfor an undisclosed amount.Both Fortis and Religare are......
Even as pharmaceutical major Ranbaxy's US woes continue unabated, the Singh family, who sold their entire stake in Ranbaxy to Japan's Daiichi Sankyo, is going ahead with a major re-branding......